HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Idebenone

HCID 3686
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
58186-27-9
Standard SMILES
COC1=C(OC)C(=O)C(CCCCCCCCCCO)=C(C)C1=O
InChIKey
JGPMMRGNQUBGND-UHFFFAOYSA-N
Molecular formula
C19H30O5
Average molar mass
338.4 g/mol
Monoisotopic mass
338.20932405

Overview

Idebenone is a member of the class of 1,4-benzoquinones which is substituted by methoxy groups at positions 2 and 3, by a methyl group at positions 5, and by a 10-hydroxydecyl group at positions 6. Initially developed for the treatment of Alzheimer's disease, benefits were modest; it was subsequently found to be of benefit for the symptomatic treatment of Friedreich's ataxia. It has a role as a ferroptosis inhibitor and an antioxidant. It is a member of 1,4-benzoquinones and a primary alcohol.

Names & identifiers

Preferred name
Idebenone
IUPAC
2-(10-hydroxydecyl)-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione
English name
Idebenone
Molecular formula
C19H30O5
Molecular weight
338.44

Names & synonyms

idebenone58186-27-9IdebenonaRaxone2-(10-hydroxydecyl)-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dioneIdebenonumSovrimahydroxydecyl ubiquinoneCV 2619Oristar hdu2-(10-Hydroxydecyl)-5,6-dimethoxy-3-methyl-1,4-benzoquinoneCV-2619
Show more names
IdebenonAvandebenoneIdebenone powder6-(10-DarumaMnesisQSA-10
6-(10-Hydroxydecyl)-2,3-dimethoxy-5-methyl-1,4-benzoquinoneDTXSID0040678HB6PN45W4JCHEBI:31687NSC-7592282-(10-Hydroxydecyl)-5,6-dimethoxy-3-methyl-p-benzoquinone2,5-Cyclohexadiene-1,4-dione, 2-(10-hydroxydecyl)-5,6-dimethoxy-3-methyl-DTXCID8020678

Database identifiers

CAS
58186-27-9
PubChem CID
3686
DTXSID
DTXSID0040678
ChEMBL
CHEMBL252556
ChEBI
CHEBI:31687
UNII

Properties

Computed structural properties

XLogP
4.3
Topological polar surface area
72.8 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
5
Rotatable bonds
12
Heavy atoms
24
Formal charge
0
Complexity
502

Experimental & physicochemical properties

CosmeticsCosmetic ingredients (Hydroxydecyl Ubiquinone) -> CIR (Cosmetic Ingredient Review)
LogP2.96
Human DrugsEMA approved medicines: Human medicine
Collision Cross Section · 2 items

181.21 Ų [M+K]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

178.6 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

Physicochemical properties

Melting point
52 · 52-550C
Boiling point
497.3 · 497.3±45.0 °C(Predicted)
Density
1.08 · 1.08±0.1 g/cm3(Predicted)
storage temp.
room temp
solubility
Soluble in DMSO (up to 25 mg/ml).
pka
15.2 · 15.20±0.10(Predicted)
form
Solid

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 5 items

This chemical does not meet GHS hazard criteria for 25% (1 of 4) of reports.

Danger

H228 (25%): Flammable solid [Danger Flammable solids]

P210, P240, P241, P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P370+P378, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 4 reports by companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Hazard information

Hazard Classes and CategoriesFlam. Sol. 2 (25%)

Toxicology

Toxicity SummarySafe in the present practices of use and concentration. Ingredient, concentration, and use information are available in documents discoverable at https://cir-reports.cir-safety.org

Safety data

wgk
3
rtecs
GU5290000
hs_code
2933399990
Signal word
Warning
Symbol(GHS)
GHS07
hazard_code
Xi
Hazard statements
H302-H315-H319-H332-H335
Precautionary statements
P261-P280-P305+P351+P338

Chemistry & industry

Pharmacology

ATC Code · 3 items

N06BX13

N - Nervous system

QN - Nervous system

Mechanism of Action · 1 item

Idebenone is a synthetic analogue of ubiquinone (also known as Coenzyme Q10), a vital cell antioxidant and essential component of the Electron Transport Chain (ETC). It has been proposed that by interacting with the ETC, idebenone increases ATP production required for mitochondrial function, reduces free radicals, inhibits lipid peroxidation, and consequently protects the lipid membrane and mitochondria from oxidative damage. More specifically, idebenone is thought to transfer electrons directly to complex III of the mitochondrial ETC, thereby circumventing complex I and restoring cellular energy (ATP) generation.

Metabolism/Metabolites · 1 item

Metabolism occurs by means of oxidative shortening of the side chain and by reduction of the quinone ring and conjugation to glucuronides and sulphates. Idebenone shows a high first pass metabolism resulting in conjugates of idebenone (glucuronides and sulphates (IDE-C)) and the Phase I metabolites QS10, QS6, and QS4 as well as their corresponding Phase II metabolites (glucuronides and sulphates (QS10+QS10-C, QS6+QS6-C, QS4+QS4-C)). The main metabolites in plasma are IDE-C and QS4+QS4-C.

MeSH Pharmacological ClassificationNaturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues.
Absorption, Distribution and Excretion · 3 items

After oral administration, idebenone is rapidly absorbed. On repeat dosing, maximum plasma concentrations of idebenone are reached on average within 1 hour (median 0.67 h range: 0.33-2.00 h). Food increases the bioavailability of idebenone by approximately 5-7-fold and i therefore should always be administered with food.

The main route of elimination is metabolism, with the majority of dose excreted via the kidneys as metabolites. After a single or repeated oral dose of 750 mg of idebenone, QS4+QS4-C were the most prominent idebenone-derived metabolites in urine, representing on average between 49.3% and 68.3% of the total administered dose. QS6+QS6 represented 6.45% to 9.46%, whereas QS10+QS10-C and IDE+IDE-C were close to 1% or below.

Related reactions

38 records
New reaction record
HRID 147968 reaction equation
HRID 147968As reactant
HRID 299093 reaction equation
HRID 299093As product
HRID 370412 reaction equation
HRID 370412As reactant
HRID 580246 reaction equation
HRID 580246As reactant
HRID 637893 reaction equation
HRID 637893As product
HRID 637894 reaction equation
HRID 637894As product
HRID 637895 reaction equation
HRID 637895As product
HRID 637896 reaction equation
HRID 637896As product
PreviousPage 1 of 5

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
HB6PN45W4J
EC Number
814-253-7
Nikkaji
J22.706D
color
Orange
Merck
14 · 14,4888
Stability
1 year · Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 3 months.
Cosmetics Ingredients Functions
ANTIOXIDANT
InChI
InChI=1S/C19H30O5/c1-14-15(12-10-8-6-4-5-7-9-11-13-20)17(22)19(24-3)18(23-2)16(14)21/h20H,4-13H2,1-3H3
InChIKey
JGPMMRGNQUBGND-UHFFFAOYSA-N
SMILES
C1(=O)C(OC)=C(OC)C(=O)C(C)=C1CCCCCCCCCCO
LogP
3.49 · 3.490 (est)
CAS DataBase Reference
58186 · 58186-27-9(CAS DataBase Reference)
FDA UNII
6 PN45W4J · HB6PN45W4J
ATC code
6 BX13 · N06BX13
Comptox DTXSID
40678 · DTXSID0040678
UNSPSC Code
41116107 · 41116107
NACRES
25 · NA.25
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
302 · H302-H315-H319-H332-H335
Precautionary statements
261 · P261-P280-P305+P351+P338
Hazard Codes
Xi
WGK Germany
3 · 3
RTECS
5290000 · GU5290000
HS Code
2933399990 · 2933399990

Experimental data have shown that idebenone passes the blood-brain barrier and is distributed at significant concentrations in cerebral tissue. Following oral administration pharmacologically relevant concentrations of idebenone are detectable in the aqueous humor of the eye.

Uses & manufacturing

UsesCIR ingredient: Hydroxydecyl Ubiquinone
Applications · 3 items

DescriptionIdebenone is an organic compound belonging to the quinone family, being similar to coenzyme Q-10. It is a kind of drug developed by Takeda Pharmaceutical Company for the treatment of Alzheimer’s disease and some other cognitive defects. However, these have been not very much progress associated with this indication. It is now also used for the treatment of Friedreich’s ataxia with a positive effect on cardiac hypertrophy and neurological function. However, this indication is only approved in Canada, not in Europe and US. It is now under investigation on its efficacy for the treatment of Duchenne muscular dystrophy, Leber’s hereditary optic neuropathy, mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes) as well as primary progressive multiple sclerosis. The efficacy of this drug still demands more evidences.

Usesidebenone is an anti-oxidant capable of protecting the skin from a variety of free-radical attacks, including the formation of secondary chemicals that negatively affect skin physiology. It is said to improve intrinsic as well as extrinsic skin damage caused by freeradical formation. Idebenone is a synthetically manufactured form of coenzyme Q10 and has a smaller molecular structure. This allows it to penetrate the skin and apparently the cellular membrane. Clinical studies demonstrate a visible improvement in photodamaged skin, reduced skin roughness and dryness, decreased fine lines and wrinkles, and increased skin hydration. In addition, idebenone helps improve hyperpigmentation because its molecular structure is similar to that of hydroquinone. Although most of the associated benefits are seen primarily in the epidermis, some increase in dermal collagen has also been confirmed. Idebenone has been used for such health-related problems as Alzheimer’s and heart disease.

General DescriptionIdebenone is a short-chain benzoquinone drug. It is a structural relative of ubiquinone (Coenzyme Q10) that protects the CNS from the effects of ischemia via improving brain metabolism. It is reported to be of potential use in the management of patients with cerebral apoplexy, cerebral arteriosclerosis and related disorders.

Upstream & downstream products

Upstream raw materials

HexaneN,N-DimethylformamideBasic Orange 210-acetoxycarbonyl chlorideCresolPotassium Phosphate MonobasicDichloromethane3,4,5-Trimethoxytoluene

Downstream products

Idebenone Sulfate
Additional notes · 1 item

DefinitionChEBI: Idebenone is a member of the class of 1,4-benzoquinones which is substituted by methoxy groups at positions 2 and 3, by a methyl group at positions 5, and by a 10-hydroxydecyl group at positions 6. Initially developed for the treatment of Alzheimer's disease, benefits were modest; it was subsequently found to be of benefit for the symptomatic treatment of Friedreich's ataxia. It has a role as an antioxidant and a ferroptosis inhibitor. It is a primary alcohol and a member of 1,4-benzoquinones.